Viatris, blocked from advertising Viagra directly under China's ban on prescription-drug ads and its taboo around intimacy, let real couples' time-lapse portraits carry the message instead, with the brand surfacing only as the pill's silhouette in the final frame

the problem

Can't advertise the drug or discuss its purpose openly in China

background

what everyone would do

Facing a legal ban on prescription-drug advertising and a cultural taboo around discussing the product's actual purpose, the available default was to stay largely silent on the category in China, or fall back on generic, category-vague messaging that avoided the taboo but also avoided saying anything meaningfully connected to the product's real function.

what they saw

Viatris saw that what was actually forbidden was making a direct claim about the drug's efficacy or discussing its clinical purpose openly, not communicating about the underlying human experience the product served, long-term intimacy and emotional connection between real couples. Rather than staying silent or going fully generic, they built an unbranded art and photography piece about the emotional subject the drug ultimately supports, and let a minimal, deferred brand cue, the pill's diamond silhouette appearing only in the closing frame, do the identification work no direct statement was legally or culturally permitted to make.

the move

Instead of an ad for the drug, Ogilvy Shanghai produced a time-lapse and long-exposure art and photography piece documenting three real couples' intimacy and emotional bond over time, released as an unbranded piece around Valentine's Day. The Viagra brand only appears at the very end, via the pill's diamond silhouette and a closing line.

why it works

Building the entire piece around real couples' time-lapse portraits and the passage of time in long relationships let Viatris communicate the emotional territory the product actually serves without ever making a claim about duration, efficacy, or clinical purpose that the advertising ban and cultural taboo both forbade. Because the brand only surfaced at the very end, through the pill's recognizable silhouette rather than any explicit statement, viewers who understood the reference could connect the emotional story to the product themselves, while the content remained fully compliant and culturally acceptable to anyone who didn't make that connection, letting the same piece work as both subtle advertising and standalone unbranded art. This is precisely why the work won the first-ever Pharma Grand Prix at Cannes Lions 2025, with jurors specifically praising how it conveyed intimacy and product benefit with subtlety while working around the ban on duration or efficacy claims, a result that required navigating the restriction with genuine craft rather than avoiding the category altogether.

the payoff

The work won the first-ever Pharma Grand Prix at Cannes Lions 2025 plus the Grand Prix for Film Craft: Cinematography, with jurors specifically praising how it conveyed intimacy and product benefit with subtlety while working around the ban on any duration or efficacy claims. No independent reach, sales-lift, or brand-awareness figures were disclosed in the sources found — the confirmed outcome is critical and industry recognition, not a disclosed commercial result.

where it breaks

The mechanism depends on the audience actually being able to recognize and correctly interpret the deferred brand cue, since a silhouette or symbol too subtle or unfamiliar risks the entire piece failing to connect back to the product at all, leaving beautiful but commercially meaningless content. It also depends on the underlying emotional territory genuinely being adjacent enough to the product's real function that the connection feels earned rather than a stretch, a piece about an unrelated emotional theme with a brand logo tacked onto the end wouldn't carry the same implicit meaning transfer this campaign achieved by staying tightly focused on intimacy and relationship longevity. And the case's own honest disclosure, that no independent reach, sales-lift, or brand-awareness figures were found in the available sources, is a reminder that critical and industry acclaim, winning a Grand Prix, being praised by jurors, is not the same as proof the approach actually moved commercial outcomes in the restricted market it was built for.

what came after

It became a case study cited across the ad industry for how a category under a hard advertising ban and a cultural taboo can still build brand meaning through adjacent, unbranded storytelling with a minimal, deferred brand reveal, rather than staying silent or going generic.

references

1. [1]Ogilvy: Viatris' Make Love LastWPP, 2025wpp.com
2. [2]Pharma Lions: WPP's Ogilvy and VML Fill Up Their CabinetsCreative Salon, 2025creative.salon

keep it

same kind of clever

• 2000 · AIGA Design for DemocracyAfter Florida's 'butterfly ballot' cost thousands of voters their intended vote, the people who fixed it weren't election lawyers — they were typographers.
• 2001 · Richard Ankrom / CaltransAn artist tired of missing his exit built a Caltrans-perfect sign and installed it himself
• 2017 · Behavioural Economics Team of the Australian Government (BETA) / Australian Taxation OfficeAustralia's tax office cut inflated deduction claims by writing to the accountant, not the taxpayer